Consensus document on improving hypertension management in asian patients, taking into account asian characteristics

Hypertension

Volumn 71, Issue 3, 2018, Pages 375-382

  Kario, Kazuomi ^a   Chen, Chen Huan ^b   Park, Sungha ^c   Park, Chang Gyu ^d   Hoshide, Satoshi ^a   Cheng, Hao Min ^b   Huang, Qi Fang ^e   Wang, Ji Guang ^e  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Yonsei University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; MASKED HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SECONDARY PREVENTION; WHITE COAT HYPERTENSION; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CONSENSUS; DISEASE MANAGEMENT; ETHNOLOGY; FEMALE; MALE; MIDDLE AGED; PHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; RISK ASSESSMENT; STANDARDS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; CONSENSUS; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 85047941806     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.10238     Document Type: Article

References (115)

1. Kario K. Evidence and perspectives on the 24-hour management of hypertension: hemodynamic biomarker-initiated 'anticipation medicine' for zero cardiovascular event. Prog Cardiovasc Dis. 2016;59:262-281. doi: 10.1016/j.pcad.2016.04.001.
2. Kario K, Tomitani N, Matsumoto Y, Hamasaki H, Okawara Y, Kondo M, Nozue R, Yamagata H, Okura A, Hoshide S. Research and development of information and communication technology-based home blood pressure monitoring from morning to nocturnal hypertension. Ann Glob Health. 2016;82:254-273. doi: 10.1016/j.aogh.2016.02.004.
3. Park JB, Kario K, Wang JG. Systolic hypertension: an increasing clinical challenge in Asia. Hypertens Res. 2015;38:227-236. doi: 10.1038/hr.2014.169.
4. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008;118:2702-2709. doi: 10.1161/CIRCULATIONAHA. 108.790048.
5. Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, Suh I, Rodgers A; Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension. 2003;42:69-75. doi: 10.1161/01. HYP.0000075083.04415.4B.
6. Arima H, Murakami Y, Lam TH, Kim HC, Ueshima H, Woo J, Suh I, Fang X, Woodward M; Asia Pacific Cohort Studies Collaboration. Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region. Hypertension. 2012;59:1118-1123. doi: 10.1161/HYPERTENSIONAHA.111.187252.
7. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T. Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res. 2003;26:521-525.
8. Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, Kajii E, Pickering TG, Kario K; Jichi Medical School Cohort Investigators Group. Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res. 2008;31:1323-1330. doi: 10.1291/hypres.31.1323.
9. Hoshide S, Wang JG, Park S, Chen CH, Cheng HM, Huang QF, Park CG, Kario K. Treatment considerations of clinical physician on hypertension management in Asia. Curr Hypertens Rev. 2016;12:164-168.
10. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508-515. doi: 10.1016/j.jacc.2005.03.070.
11. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
12. Excellence. NIfHaC. Hypertension: Clinical Management of Primary Hypertension in Adults. Cg127. Available at: http://guidance.nice.org.uk/CG127/Guidance/pdf/English. 2011. Accessed July 7, 2017.
13. Omboni S, Aristizabal D, De la Sierra A, et al; ARTEMIS (international Ambulatory blood pressure Registry: TEleMonitoring of hypertension and cardiovascular rISk project) Investigators. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34:2187-2198. doi: 10.1097/HJH.0000000000001074.
14. Wang JG, Kario K, Park JB, Chen CH. Morning blood pressure monitoring in the management of hypertension. J Hypertens. 2017;35:1554-1563. doi: 10.1097/HJH.0000000000001379.
15. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-1406.
16. Kario K, Saito I, Kushiro T, Teramukai S, Ishikawa Y, Mori Y, Kobayashi F, Shimada K. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension. 2014;64:989-996. doi: 10.1161/HYPERTENSIONAHA.114.04262.
17. Hoshide S, Kario K, de la Sierra A, Bilo G, Schillaci G, Banegas JR, Gorostidi M, Segura J, Lombardi C, Omboni S, Ruilope L, Mancia G, Parati G. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study. Hypertension. 2015;66:750-756. doi: 10.1161/HYPERTENSIONAHA.115.05958.
18. Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Matsui Y, Nakamura A, Fukutomi M, Eguchi K, Ishikawa J, Kario K; J-HOP Study Group. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population: the Japan Morning Surge-Home Blood Pressure Study. Hypertension. 2016;68:54-61. doi: 10.1161/HYPERTENSIONAHA.116.07201.
19. Asayama K, Ohkubo T, Metoki H, Obara T, Inoue R, Kikuya M, Thijs L, Staessen JA, Imai Y; Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res. 2012;35:1102-1110. doi: 10.1038/hr.2012.125.
20. Kario K, Hoshide S, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, Yano Y, Eguchi K, Matsui Y, Shimizu M, Ishikawa J, Ishikawa S; JHOP Study Group. Sleep blood pressure self-measured at home as a novel determinant of organ damage: Japan Morning Surge Home Blood Pressure (J-HOP) Study. J Clin Hypertens (Greenwich). 2015;17:340-348. doi: 10.1111/jch.12500.
21. Kimura G, Dohi Y, Fukuda M. Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events. Hypertens Res. 2010;33:515-520. doi: 10.1038/hr.2010.47.
22. Boggia J, Li Y, Thijs L, et al; International Database on Ambulatory blood pressure monitoring in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219-1229. doi: 10.1016/S0140-6736(07)61538-4.
23. Li Y, Wang JG. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension. 2013;61:278-283. doi: 10.1161/HYPERTENSIONAHA. 111.00217.
24. Marler JR, Price TR, Clark GL, Muller JE, Robertson T, Mohr JP, Hier DB, Wolf PA, Caplan LR, Foulkes MA. Morning increase in onset of ischemic stroke. Stroke. 1989;20:473-476.
25. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E; MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:1315-1322.
26. Kuwajima I, Mitani K, Miyao M, Suzuki Y, Kuramoto K, Ozawa T. Cardiac implications of the morning surge in blood pressure in elderly hypertensive patients: relation to arising time. Am J Hypertens. 1995;8:29-33. doi: 10.1016/0895-7061(94)00154-4.
27. Li Y, Thijs L, Hansen TW, et al; International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040-1048. doi: 10.1161/HYPERTENSIONAHA.109.137273.
28. Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens. 2005;18(2 pt 1):149-151. doi: 10.1016/j.amjhyper.2004.09.007.
29. Kario K, Saito I, Kushiro T, Teramukai S, Tomono Y, Okuda Y, Shimada K. Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST Study. J Am Coll Cardiol. 2016;67:1519-1527. doi: 10.1016/j.jacc.2016.01.037.
30. Lambert EA, Chatzivlastou K, Schlaich M, Lambert G, Head GA. Morning surge in blood pressure is associated with reactivity of the sympathetic nervous system. Am J Hypertens. 2014;27:783-792. doi: 10.1093/ajh/hpt273.
31. Osanai T, Okuguchi T, Kamada T, Fujiwara N, Kosugi T, Saitoh G, Katoh T, Nakano T, Takahashi K, Guan W, Okumura K. Salt-induced exacerbation of morning surge in blood pressure in patients with essential hypertension. J Hum Hypertens. 2000;14:57-64.
32. Morgan T. Adequate blood pressure control: perception and reality. Eur Heart J. 1997;18 (suppl E):E9-E13.
33. Council on Hypertension of the Chinese Society of Cardiology. Chinese expert consensus on early morning blood pressure. Chin J Cardiol. 2014;42:721-725.
34. Wang JG, Kario K, Chen CH, Park JB, Hoshide S, Huo Y, Lee HY, Li Y, Mogi M, Munakata M, Park S, Zhu D. Management of morning hypertension: a Consensus Statement of an Asian Expert Panel. J Clin Hypertens. 2017. In press.
35. Cheng HM, Park S, Huang Q, Hoshide S, Wang JG, Kario K, Park CG, Chen CH; Characteristics on the Management of Hypertension in Asia -Morning Hypertension Discussion Group (COME Asia MHDG). Vascular aging and hypertension: implications for the clinical application of central blood pressure. Int J Cardiol. 2017;230:209-213. doi: 10.1016/j. ijcard.2016.12.170.
36. Mitchell GF, Wang N, Palmisano JN, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS. Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham Heart Study. Circulation. 2010;122:1379-1386. doi: 10.1161/CIRCULATIONAHA.109.914507.
37. Farasat SM, Morrell CH, Scuteri A, Ting CT, Yin FC, Spurgeon HA, Chen CH, Lakatta EG, Najjar SS. Pulse pressure is inversely related to aortic root diameter implications for the pathogenesis of systolic hypertension. Hypertension. 2008;51:196-202. doi: 10.1161/HYPERTENSIONAHA.107.099515.
38. Yoon SH, Ohno Y, Araki M, et al. Comparison of aortic root anatomy and calcification distribution between Asian and Caucasian patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2015;116:1566-1573. doi: 10.1016/j.amjcard.2015.08.021.
39. Virmani R, Avolio AP, Mergner WJ, Robinowitz M, Herderick EE, Cornhill JF, Guo SY, Liu TH, Ou DY, O'Rourke M. Effect of aging on aortic morphology in populations with high and low prevalence of hypertension and atherosclerosis. Comparison between occidental and Chinese communities. Am J Pathol. 1991;139:1119-1129.
40. Avolio A. Genetic and environmental factors in the function and structure of the arterial wall. Hypertension. 1995;26:34-37.
41. Reeve JC, Abhayaratna WP, Davies JE, Sharman JE. Central hemodynamics could explain the inverse association between height and cardiovascular mortality. Am J Hypertens. 2014;27:392-400. doi: 10.1093/ajh/hpt222.
42. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308:875-881. doi: 10.1001/2012. jama.10503.
43. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
44. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31:1925-1938.
45. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115-2127. doi: 10.1291/hypres.31.2115.
46. Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kikuchi K, Ito S, Eto T, Kimura G, Imaizumi T, Takishita S, Ueshima H; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010;56:196-202. doi: 10.1161/HYPERTENSIONAHA.109.146035.
47. Chiang CE, Wang TD, Lin TH, et al. The 2017 focused update of the guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the management of hypertension. Acta Cardiol Sin. 2017;33:213-225.
48. Esler M, Hastings J, Lambert G, Kaye D, Jennings G, Seals DR. The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol Regul Integr Comp Physiol. 2002;282:R909-R916. doi: 10.1152/ajpregu.00335.2001.
49. Monahan KD. Effect of aging on baroreflex function in humans. Am J Physiol Regul Integr Comp Physiol. 2007;293:R3-R12. doi: 10.1152/ajpregu.00031.2007.
50. Zemel MB, Sowers JR. Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol. 1988;61:7H-12H.
51. Virdis A, Bruno RM, Neves MF, Bernini G, Taddei S, Ghiadoni L. Hypertension in the elderly: an evidence-based review. Curr Pharm Des. 2011;17:3020-3031.
52. Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and metaanalysis. Lancet. 2016;387:435-443. doi: 10.1016/S0140-6736(15)00805-3.
53. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957-967. doi: 10.1016/S0140-6736(15)01225-8.
54. Williamson JD, Supiano MA, Applegate WB, et al; SPRINT Research Group. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315:2673-2682. doi: 10.1001/jama.2016.7050.
55. Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. J Am Coll Cardiol. 2017;69:486-493. doi: 10.1016/j.jacc.2016.10.077.
56. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. doi: 10.1056/NEJMoa0801369.
57. Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines [published online ahead of print November 13, 2017]. Hypertension. http://hyper.ahajournals.org/content/hypertensionaha/early/2017/11/10/HYP.0000000000000065.full.pdf.
58. Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, Strandberg TE, Petrovic M. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA. 2015;314:170-180. doi: 10.1001/jama.2015.7517.
59. Kim YD, Jung YH, Saposnik G. Traditional risk factors for stroke in East Asia. J Stroke. 2016;18:273-285. doi: 10.5853/jos.2016.00885.
60. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;CD000028.
61. Bavishi C, Goel S, Messerli FH. Isolated systolic hypertension: an update after SPRINT. Am J Med. 2016;129:1251-1258. doi: 10.1016/j.amjmed. 2016.08.032.
62. Cushman WC, Evans GW, Byington RP, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585. doi: 10.1056/NEJMoa1001286.
63. Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717.
64. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S; Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707-716. doi: 10.1097/01.hjh.0000052492.18130.07.
65. Park S, Kario K, Park CG, Huang QF, Cheng HM, Hoshide S, Wang JG, Chen CH; Characteristics On the ManagEment of Hypertension in Asia-Morning Hypertension Discussion Group (COME Asia MHDG). Target blood pressure in patients with diabetes: Asian perspective. Yonsei Med J. 2016;57:1307-1311. doi: 10.3349/ymj.2016.57.6.1307.
66. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815-822. doi: 10.1016/S0140-6736(12)60033-6.
67. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621-630. doi: 10.1007/s10157-009-0199-x.
68. Park JI, Baek H, Jung HH. Prevalence of chronic kidney disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013. J Korean Med Sci. 2016;31:915-923. doi: 10.3346/jkms.2016.31.6.915.
69. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371:2173-2182. doi: 10.1016/S0140-6736(08)60952-6.
70. Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, Tsuruya K, Iida M, Kiyohara Y. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant. 2010;25:2557-2564. doi: 10.1093/ndt/gfq062.
71. Parati G, Ochoa JE, Bilo G, et al; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA). Hypertension in chronic kidney disease part 2: role of ambulatory and home blood pressure monitoring for assessing alterations in blood pressure variability and blood pressure profiles. Hypertension. 2016;67:1102-1110. doi: 10.1161/HYPERTENSIONAHA.115.06896.
72. Fukuda M, Mizuno M, Yamanaka T, Motokawa M, Shirasawa Y, Nishio T, Miyagi S, Yoshida A, Kimura G. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension. 2008;52:1155-1160. doi: 10.1161/HYPERTENSIONAHA.108.115329.
73. Fukuda M, Kimura G. Salt sensitivity and nondippers in chronic kidney disease. Curr Hypertens Rep. 2012;14:382-387. doi: 10.1007/s11906-012-0286-3.
74. Li Y, Wang JG, Gao P, Guo H, Nawrot T, Wang G, Qian Y, Staessen JA, Zhu D. Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Press Monit. 2005;10:125-134.
75. Pogue V, Rahman M, Lipkowitz M, Toto R, Miller E, Faulkner M, Rostand S, Hiremath L, Sika M, Kendrick C, Hu B, Greene T, Appel L, Phillips RA; African American Study of Kidney Disease and Hypertension Collaborative Research Group. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension. 2009;53:20-27. doi: 10.1161/HYPERTENSIONAHA.108.115154.
76. Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res. 2012;35:695-701. doi: 10.1038/hr.2012.26.
77. Chiang CE, Wang TD, Ueng KC, et al. 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension. J Chin Med Assoc. 2015;78:1-47. doi: 10.1016/j.jcma.2014.11.005.
78. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
79. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-2219. doi: 10.1093/eurheartj/eht151.
80. Liu LS; Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579-615.
81. Shimamoto K, Ando K, Fujita T, et al; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253-390. doi: 10.1038/hr.2014.20.
82. Shin J, Park JB, Kim KI, Kim JH, Yang DH, Pyun WB, Kim YG, Kim GH, Chae SC; Guideline Committee of the Korean Society of Hypertension. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations. Clin Hypertens. 2015;21:3. doi: 10.1186/s40885-014-0014-1.
83. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32:3-15. doi: 10.1097/HJH. 0000000000000065.
84. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B; Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. doi: 10.1136/bmj.d4891.
85. Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864-2883.
86. Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998;31:1622-1626.
87. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005;112:1687-1691. doi: 10.1161/CIRCULATIONAHA.105.553438.
88. Lip GY, Frison L, Grind M; SPORTIF Invetigators. Effect of hypertension on anticoagulated patients with atrial fibrillation. Eur Heart J. 2007;28:752-759. doi: 10.1093/eurheartj/ehl504.
89. Arima H, Anderson C, Omae T, Woodward M, MacMahon S, Mancia G, Bousser MG, Tzourio C, Rodgers A, Neal B, Chalmers J; Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Collaborative Group. Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial. Stroke. 2012;43:1675-1677. doi: 10.1161/STROKEAHA.112.651448.
90. Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Otsuka T, Tomita H, Origasa H; J-RHYTHM Registry Investigators. Impact of blood pressure control on thromboembolism and major hemorrhage in patients with nonvalvular atrial fibrillation: a subanalysis of the J-RHYTHM registry. J Am Heart Assoc. 2016;5:e004075. doi: 10.1161/JAHA.116.004075.
91. Kim AS, Johnston SC. Global variation in the relative burden of stroke and ischemic heart disease. Circulation. 2011;124:314-323. doi: 10.1161/CIRCULATIONAHA.111.018820.
92. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, Lim S, Danaei G, Ezzati M, Powles J; Global Burden of Diseases Nutrition and Chronic Diseases Expert Group. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624-634.
93. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009;23:363-384. doi: 10.1038/jhh.2008.144.
94. Wang WT, You LK, Chiang CE, Sung SH, Chuang SY, Cheng HM, Chen CH. Comparative effectiveness of blood pressure-lowering drugs in patients who have already suffered from stroke: traditional and Bayesian network meta-analysis of randomized trials. Medicine (Baltimore). 2016;95:e3302. doi: 10.1097/MD.0000000000003302.
95. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
96. Katsanos AH, Filippatou A, Manios E, Deftereos S, Parissis J, Frogoudaki A, Vrettou AR, Ikonomidis I, Pikilidou M, Kargiotis O, Voumvourakis K, Alexandrov AW, Alexandrov AV, Tsivgoulis G. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69:171-179. doi: 10.1161/HYPERTENSIONAHA.116.08485.
97. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2741-2748. doi: 10.1161/01.STR.0000092488.40085.15.
98. Kang J, Ko Y, Park JH, Kim WJ, Jang MS, Yang MH, Lee J, Lee J, Han MK, Gorelick PB, Bae HJ. Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology. 2012;79:2018-2024. doi: 10.1212/WNL.0b013e3182749eb8.
99. Wang Y, Wang J, Meng P, Liu N, Ji N, Zhang G, Xu B, Zhou X, Sun Y, Xu Y, Hui R, He M. Mid-term blood pressure variability is associated with clinical outcome after ischemic stroke. Am J Hypertens. 2017; 30:968-977.
100. Tao Y, Xu J, Song B, Xie X, Gu H, Liu Q, Zhao L, Wang Y, Xu Y, Wang Y. Short-term blood pressure variability and long-term blood pressure variability: which one is a reliable predictor for recurrent stroke. J Hum Hypertens. 2017;31:568-573. doi: 10.1038/jhh.2017.32.
101. Manning L, Hirakawa Y, Arima H, et al; INTERACT2 Investigators. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol. 2014;13:364-373. doi: 10.1016/S1474-4422(14)70018-3.
102. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375:906-915. doi: 10.1016/S0140-6736(10)60235-8.
103. Wright JT Jr, Williamson JD, Whelton PK, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116. doi: 10.1056/NEJMoa1511939.
104. Kario K. Essential Manual of 24-Hour Blood Pressure Management From Morning to Nocturnal Hypertension. London, UK: Wiley-Blackwell; 2015: Chapter 1; 7-9.
105. Kario K. Hypertension: benefits of strict blood-pressure lowering in hypertension. Nat Rev Cardiol. 2016;13:125-126. doi: 10.1038/nrcardio.2016.13.
106. Eguchi K, Kario K, Hoshide Y, Hoshide S, Ishikawa J, Morinari M, Ishikawa S, Shimada K. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens. 2004;17:112-117.
107. Kario K, Hoshide S. Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study. Hypertension. 2015;65:729-735. doi: 10.1161/HYPERTENSIONAHA.114.04935.
108. Wang JG, Kario K, Lau T, Wei YQ, Park CG, Kim CH, Huang J, Zhang W, Li Y, Yan P, Hu D; Asian Pacific Heart Association. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association. Hypertens Res. 2011;34:423-430. doi: 10.1038/hr.2010.259.
109. Kario K, Hoshide S, Uchiyama K, Yoshida T, Okazaki O, Noshiro T, Aoki H, Mizuno H, Matsumoto Y. Dose timing of an angiotensin II receptor blocker/calcium channel blocker combination in hypertensive patients with paroxysmal atrial fibrillation. J Clin Hypertens (Greenwich). 2016;18:1036-1044. doi: 10.1111/jch.12814.
110. Kario K, Tomitani N, Kanegae H, Ishii H, Uchiyama K, Yamagiwa K, Shiraiwa T, Katsuya T, Yoshida T, Kanda K, Hasegawa S, Hoshide S. ARB/calcium-channel blocker combination on uncontrolled nocturnal hypertension evaluated by information and communication technologybased nocturnal home blood pressure monitoring -The NOCTURNE Study. Circ J. 2017;81:948-957.
111. Kario K, Saito I, Kushiro T, Teramukai S, Yaginuma M, Mori Y, Okuda Y, Kobayashi F, Shimada K. Persistent olmesartan-based blood pressurelowering effects on morning hypertension in Asians: the HONEST study. Hypertens Res. 2016;39:334-341. doi: 10.1038/hr.2015.148.
112. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ; ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428. doi: 10.1056/NEJMoa0806182.
113. Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Effect of catheter-based renal denervation on morning and nocturnal blood pressure: insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension. 2015;66:1130-1137. doi: 10.1161/HYPERTENSIONAHA. 115.06260.
114. Kario K. PREFACE: is renal denervation effective option for management of hypertension in Asia? Curr Hypertens Rev. 2017;13:2-5. doi: 10 .2174/157340211301170619083619.
115. Kario K, Bhatt DL, Brar S, Bakris GL. Differences in dynamic diurnal blood pressure variability between Japanese and American treatmentresistant hypertensive populations. Circ J. 2017;81:1337-1345. doi: 10.1253/circj.CJ-16-1237.